期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心肾联系共同机制研究进展 被引量：4

原文传递
导出
摘要 近年来心、肾疾病之间的关系引起了广泛关注,慢性肾脏病与心血管病二者有共同发病机制,互为危险因素。strain vessel结构在心肾联系的共同机制方面起重要作用,尤其与蛋白尿关系密切。本文就心肾联系的流行病学,肾脏血流动力学、病理生理等与心肾联系的研究进展作一综述。
作者 许红兰 崔永军 邹作君
机构地区 青岛市市立医院肾内科
出处 《中华实用诊断与治疗杂志》 2014年第5期431-433,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 心肾联系 肾脏血流动力学 STRAIN vessel结构 微量白蛋白尿
分类号 R541 [医药卫生—心血管疾病] R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献16

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量：184
  • 2徐丽平.维持性血液透析患者多因素Cox生存分析[J].中华实用诊断与治疗杂志,2013,27(3):311-312. 被引量：8
  • 3杨毅宁,甘振业,马依彤.伴早期肾功能不全冠状动脉狭窄患者肾功能与冠状动脉病变程度相关性分析[J].中华实用诊断与治疗杂志,2010,24(6):550-552. 被引量：3
  • 4Matsushita K, van der Velde M, Astor B C, et al. Association of estimated glomerular filtration rate and albuminuria with all cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis[J]. Lancet,2010,375(9731) :2073- 2081.
  • 5陈健,陈昱,唐勇,黄晓红,陈漫天,周卿,张亚臣,沈成兴,李毅刚.骨桥蛋白及肾功能与冠状动脉病变程度的研究[J].中华实用诊断与治疗杂志,2013,27(5):430-432. 被引量：3
  • 6Forlemu A, Menanga A, Ashuntantang G, et al. Urinary protein excretion is associated with left ventricular hypertrophy in treatment naive hypertensive patients in an African hospital setting[J]. Cardiorenal Med,2013,3(1) :57-62.
  • 7Ito S, Nagasawa T, Abe M, et al. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk[J]. Hypertens Res,2009,32(2) :115-121.
  • 8Cosson E, Pham I, Valensi P, et al. Impaired coronary endot helium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries[J]. Diabetes Care, 2006,29(1):107 -112.
  • 9Kovesdy C P, Bleyer A J, Molnar M Z, et al. Blood pressure and mortality in U. S. veterans with chronic kidney disease: a cohort study[J]. Ann Intern Med,2013,159(4):233-242.
  • 10Mori T, Cowley Jr A W. Role of pressure in angiotensin II- induced renal injury: chronic servo-control of renal perfusion pressure in rats[J]. Hypertension,2004,43(4):752-759.

二级参考文献50

  • 1史浩,陈楠,张文,任红,徐耀文,沈平雁,王伟铭,俞海瑾,李晓,冯晓蓓.简化MDRD公式预测慢性肾病患者肾小球滤过率的应用评价及校正[J].中国实用内科杂志,2006,26(5):665-669. 被引量：89
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量：729
  • 3倪俊玮,张瑞岩,张奇,张建盛,胡健,沈卫峰.慢性肾功能减退患者临床特征与冠状动脉病变分析[J].国际心血管病杂志,2006,33(6):425-427. 被引量：9
  • 4方欣,管思明.骨桥蛋白与高血压血管重构[J].心脏杂志,2007,19(2):232-233. 被引量：7
  • 5Ruilope L M, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study[J]. J AmSoe Nephrol,2001,12(2):218-225.
  • 6van der Harst P, Smilde T D, Buikema H, et al. Vascular function and mild renal impairment in stable coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 2006,26 (2): 379-384.
  • 7McCullough P A, Jurkovitz C T, Pergola P E, et al. Independent components of chronic kidney disease as a cardiovascular risk state: Result from the Kidney Early Evaluation Program (KEEP)[J]. Arch Intern Med, 2007,167 (11) : 1122-1129.
  • 8Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community[J]. J Am Coll Cardiol,2003,41(1): 47-55.
  • 9National Kidney Foundation. K/DOQ I clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis,2002,39(2 Supple1) :s1-s266.
  • 10Levey A S, Bosch J P, Levis J B, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation[J]. Ann Intern Med, 1999,130(6) :461-470.

共引文献194

同被引文献68

  • 1郭华,马行一,王伟.心肾综合征的临床研究进展[J].心血管病学进展,2009,30(6):963-966. 被引量：11
  • 2杜金行,李春岩,贺琳.试论心肾相交、水火既济[J].中华中医药杂志,2007,22(2):77-80. 被引量：60
  • 3陈树林,李育良.内关、心俞与心脏相关的神经基础[J].中国针灸,1996,16(12):33-35. 被引量：45
  • 4刘玉洁.从五脏一体论治窦性心动过缓[J].中医杂志,2007,48(9):785-786. 被引量：13
  • 5ACS-PCI患者肾功能状态调查协作组,霍勇,何华.急性冠状动脉综合征接受介入治疗患者肾功能状态多中心注册研究[J].北京大学学报（医学版）,2007,39(6):624-629. 被引量：31
  • 6Shepherd J, Kastelein JJ, Bittner V, et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study[ j 1. J Am Coil C ardi- ol, 2008,51 ( 15 ) :1448 - 1454.
  • 7Barbiefi L, Yerdoia M, Sehaffer A, et al. Pre - diabetes and risk of contrast induced nephropathy in patients undergoing coronary angiogra- phy or percutaneous intervention[J]. Diabetes Res Clin Pract, 2014, 106(3) :458 -464.
  • 8National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification [ J]. Am J Kidney Dis, 2002,39 (2 Suppl 1 ) : S1 - 266.
  • 9Bakris GL, Sarafidis PA, Weir MR, et al. Renal outcomes with differ- ent fixed - dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial[ J ]. Lancet. 2010, 375(9721 ) :1173 - 1181.
  • 10Dalrymple LS1, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end- stage renal disease versus death[J]. J Gen Intern Med, 2011, 26(4) :379-385.

引证文献4

二级引证文献24

中华实用诊断与治疗杂志
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部